The regrouping of Luminal B (HER2 negative), a better discriminator of outcome and recurrence score

The regrouping of Luminal B (HER2 negative), a better discriminator of outcome and recurrence score

Abstract Background Breast cancer (BC) remains the leading cause of cancer‐related deaths worldwide. High recurrence risk Luminal BC receives adjuvant chemotherapy in addition to standard hormone therapy. Considering the heterogeneity of Luminal B BC, a more accurate classification model is urgently...

Full description

Saved in:
Bibliographic Details
Main Authors: Zheng‐Jun Yang, Yu‐Xiao Liu, Yue Huang, Zu‐Jin Chen, Hao‐Zhi Zhang, Yue Yu, Xin Wang, Xu‐Chen Cao
Format: Article
Language:English
Published: Wiley 2023-02-01
Series:Cancer Medicine
Subjects:
breast cancer
breast cancer subtype
Luminal B
prognosis
recurrence score
Online Access:https://doi.org/10.1002/cam4.5089
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/cam4.5089

Similar Items